All Stories

  1. Lorcaserin: Worthy of Further Insights? Results from Recent Research

    Article • CNS & Neurological Disorders - Drug Targets, March 2024, Bentham Science Publishers

    Prof. Giuseppe Biondi-Zoccai, Dr Enrico Romagnoli, Dr Georgios D. Kotzalidis, Professor Domenico De Berardis

  2. Actual Developments in the Antipsychotic Treatment of Psychiatric Disorders: Overcoming Challenges, Opening New Ways, and Looking at the Future

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Professor Domenico De Berardis

  3. Suicide and Genetic Biomarkers: Toward Personalized Tailored-treatment with Lithium and Clozapine

    Article • Current Pharmaceutical Design, August 2021, Bentham Science Publishers

    Professor Domenico De Berardis

  4. New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review

    Article • Current Topics in Medicinal Chemistry, June 2021, Bentham Science Publishers

    Giuseppe Magnifico, Professor Domenico De Berardis, Angelo Rinaldi

  5. Oxidative Stress in the Early Stage of Psychosis

    Article • Current Topics in Medicinal Chemistry, June 2021, Bentham Science Publishers

    Professor Domenico De Berardis, Dr Alessandro Valchera, Donato Favale

  6. ‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports

    Article • Current Neuropharmacology, October 2020, Bentham Science Publishers

    Professor Domenico De Berardis, John Corkery

  7. An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine

    Article • Current Topics in Medicinal Chemistry, April 2020, Bentham Science Publishers

    Professor Domenico De Berardis, Prof. Maurizio Pompili, Dr Alessandro Valchera, Professor Giampaolo Robert Perna

  8. Brexpiprazole for treatment-resistant major depressive disorder

    Article • Expert Opinion on Pharmacotherapy, August 2019, Taylor & Francis

    Professor Domenico De Berardis

  9. Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System

    Article • Current Pharmaceutical Design, June 2019, Bentham Science Publishers

    Dr Alessandro Valchera, Prof. Maurizio Pompili, Professor Giampaolo Robert Perna, Professor Domenico De Berardis

  10. Pharmacological management of depression in patients with multiple sclerosis

    Article • Expert Opinion on Pharmacotherapy, September 2018, Taylor & Francis

    Mauro Giovanni Carta, Professor Domenico De Berardis

  11. Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review

    Article • Current Neuropharmacology, May 2018, Bentham Science Publishers

    Professor Domenico De Berardis, Professor Giampaolo Robert Perna

  12. A focus on the adverse effects of clozapine

    Article • Therapeutic Advances in Drug Safety, February 2018, SAGE Publications

    Professor Domenico De Berardis, Professor Giampaolo Robert Perna

  13. Current and Future Perspectives on the Major Depressive Disorder: Focus on Vortioxetine

    Article • CNS & Neurological Disorders - Drug Targets, January 2017, Bentham Science Publishers

    Professor Domenico De Berardis, Professor Giampaolo Robert Perna

  14. Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Professor Giampaolo Robert Perna, Prof Andrea de Bartolomeis, Professor Domenico De Berardis

  15. The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders

    Article • Current Pharmaceutical Design, November 2016, Bentham Science Publishers

    Professor Domenico De Berardis, Professor Cristina Segura-Garcia, Professor Giampaolo Robert Perna

  16. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice

    Article • CNS Spectrums, October 2016, Cambridge University Press

    Professor Domenico De Berardis, Professor Giampaolo Robert Perna

  17. Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials

    Article • July 2016, Dove Medical Press

    Professor Giampaolo Robert Perna, Professor Domenico De Berardis

  18. Bipolar Polypharmacy

    Article • March 2016, Dove Medical Press

    Professor Giampaolo Robert Perna, Dr Alessandro Valchera, Professor Domenico De Berardis

  19. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.

    Article • CNS & Neurological Disorders - Drug Targets, January 2016, Bentham Science Publishers

    Professor Giampaolo Robert Perna, Prof Andrea de Bartolomeis, Professor Domenico De Berardis

  20. The role of melatonin in mood disorders

    Article • ChronoPhysiology and Therapy, November 2015, Dove Medical Press

    Professor Giampaolo Robert Perna, Dr Alessandro Valchera, Professor Domenico De Berardis, Gabriella Girinelli

  21. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials

    Article • Current Drug Targets, September 2015, Bentham Science Publishers

    Prof Andrea de Bartolomeis, Professor Domenico De Berardis

  22. The use of melatonin for treating sleep disorders in patients with Parkinson's disease

    Article • ChronoPhysiology and Therapy, August 2014, Taylor & Francis

    Prof. Zahiruddin Othman, Professor Timo Partonen, Professor Domenico De Berardis, Rahimah Zakaria

  23. Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

    Article • Neuropsychiatric Disease and Treatment, May 2014, Dove Medical Press

    Dr Christian Cordano, Dr Fabio Bandini, Professor Domenico De Berardis

  24. Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole

    Article • Recent Patents on Endocrine Metabolic & Immune Drug Discovery, February 2014, Bentham Science Publishers

    Professor Giampaolo Robert Perna, Professor Domenico De Berardis

  25. The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview

    Article • Current Pharmaceutical Design, September 2013, Bentham Science Publishers

    Professor Domenico De Berardis

  26. Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study

    Article • Neuropsychiatric Disease and Treatment, February 2013, Taylor & Francis

    Professor Domenico De Berardis

  27. The melatonergic system: effects on sleep and implications for the treatment of psychiatric disorders

    Article • ChronoPhysiology and Therapy, December 2011, Taylor & Francis

    Professor Domenico De Berardis

  28. The role of duloxetine in the treatment of anxiety disorders

    Article • Neuropsychiatric Disease and Treatment, July 2008, Dove Medical Press

    Professor Domenico De Berardis